MARKET WIRE NEWS
  1. Home
  2. Stock
  3. PHVS
  4. News
PHVS
Quote
Short
News
Articles
Message Board

Pharvaris N.V. (NASDAQ : PHVS ) News

Pharvaris N.V. (NASDAQ: PHVS) News Releases

PHVS News Releases
PHVS : NASDAQ
GlobeNewswire
Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting
PHVS : NASDAQ
GlobeNewswire
Pharvaris Outlines 2026 Strategic Priorities
PHVS : NASDAQ
SeekingAlpha
Oppenheimer's best small and mid-cap ideas for 2026
PHVS : NASDAQ
KlickAnalytics
PHVS Price Target Alert: $41.00. Issued by Morgan Stanley
PHVS : NASDAQ
KlickAnalytics
Overweight Recommendation Issued On PHVS By Morgan Stanley
PHVS : NASDAQ
SeekingAlpha
Pharvaris N.V. (PHVS) Discusses Topline Data From RAPIDe-3 Phase III Study of Deucrictibant for Hereditary Angioedema Transcript
PHVS : NASDAQ
KlickAnalytics
PHVS Price Target Alert: $38.00. Issued by Leerink Partners
PHVS : NASDAQ
SeekingAlpha
Pharvaris achieves primary goal in late-stage trial of deucrictibant for HAE
PHVS : NASDAQ
GlobeNewswire
Pharvaris Announces Positive Topline Data from RAPIDe-3 Pivotal Study Confirming Potential of Deucrictibant for On-Demand Treatment of HAE Attacks
PHVS : NASDAQ
SeekingAlpha
Astria Therapeutics: Updating Target Price, Biocryst Deal Expected To Go Through, Hold

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.